Market Place
Sourcing Support
All News #Library
Biotech
FDA Approves POHERDY® as First PERJETA Biosimilar
17 Nov 2025 //
BUSINESSWIRE
Poherdy, First Biosimilar To Roche`s Perjeta, Scores FDA Nod
14 Nov 2025 //
FIERCE PHARMA
EC Approves Henlius, Organon`s BILDYOS & BILPREVDA Biosimilars
19 Sep 2025 //
PHARMAWEB
FDA Approves Henlius and Organon`s Bildyos and Bilprevda
02 Sep 2025 //
PHARMAWEB
FDA Grants interchangeability to Samsung & Organon Hadlima Inj
27 May 2025 //
BUSINESSWIRE
Organon Acquires Tofidence, a Biosimilar to Actemra in US
01 Apr 2025 //
BUSINESSWIRE
EMA Validates Henlius and Organon Filing for Perjeta Biosimilar
28 Mar 2025 //
BUSINESSWIRE
Primary Endpoint Met In Ph 3 Study Of Perjeta Biosimilar HLX11
30 Sep 2024 //
PRESS RELEASE
Phase 3 Comparative Clinical Study of Prolia® and Xgeva Met Primary Endpoints
08 Apr 2024 //
BUSINESSWIRE
Organon`s Humira biosimilar gets exclusive spot on VA formulary
16 Feb 2024 //
ENDPTS
Samsung Bioepis & Organon Announce Acceptance of sBLA for Interchangeability Designation for HADLIMA
07 Nov 2023 //
GLOBENEWSWIRE
Samsung Bioepis & Organon Announce Results from Study of SB5 Humira Biosimilar
01 Aug 2023 //
GLOBENEWSWIRE
Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA
01 Jul 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.